e-learning
resources
Vienna 2012
Monday, 03.09.2012
Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Diffuse alveolar hemorrhage caused by primary antiphospholipid syndrome
R. Cartin-Ceba, T. Peikert, A. Ashrani, K. Keogh, S. Ytterberg, U. Specks (Rochester, United States Of America)
Source:
Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities
Session:
Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities
Session type:
Poster Discussion
Number:
1774
Disease area:
Interstitial lung diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Cartin-Ceba, T. Peikert, A. Ashrani, K. Keogh, S. Ytterberg, U. Specks (Rochester, United States Of America). Diffuse alveolar hemorrhage caused by primary antiphospholipid syndrome. Eur Respir J 2012; 40: Suppl. 56, 1774
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Pulmonary involvement in antiphospholipid syndrome
Source: Eur Respir Monogr 2019; 86: 124-139
Year: 2019
Case of lymphangioleiomyomatosis complicated by severe alveolar hemorrhagic syndrome
Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs)
Year: 2018
Pulmonary vasculitis presenting as acute diffuse alveolar haemorrhage (DAH)
Source: International Congress 2018 – CC5 Pulmonary vasculitis: the great chameleon
Year: 2018
Diffuse alveolar haemorrhage
Source: Eur Respir Monogr 2019; 86: 173-187
Year: 2019
Alveolar hemorrhage syndrome in children
Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children
Year: 2018
Diffuse alveolar hemorrhage and pulmonary fibrosis in MPO-ANCA-associated vasculitides
Source: Eur Respir J 2005; 26: Suppl. 49, 267s
Year: 2005
Recurrent massive pulmonary hemorrhage in the course of hereditary hemorrhagic teleangiectasia (HHT) with diffuse pulmonary arteriovenous malformations
Source: Annual Congress 2009 - Interesting case reports and case series
Year: 2009
The lung in the antiphospholipid syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 536s
Year: 2004
Primary antiphospholipid antibody syndrome with pleural effusion
Source: Eur Respir J 2004; 24: Suppl. 48, 247s
Year: 2004
Diffuse alveolar hemorrhage: how relevant is etiology?
Source: International Congress 2017 – IPF: from the bench to the bedside
Year: 2017
A rare type of hemorrhagic diathesis as a paraneoplastic syndrome
Source: Eur Respir J 2003; 22: Suppl. 45, 361s
Year: 2003
Surgery for secondary pneumothorax caused by Hermansky–Pudlak syndrome
Source: Eur Respir J 2014; 44: 1715-1717
Year: 2014
Familial progressive non-specific interstitial pneumonia
Source: Eur Respir J 2004; 24: Suppl. 48, 505s
Year: 2004
Acute respiratory distress syndrome secondary to antisynthetase syndrome is reversible with tacrolimus
Source: Eur Respir J 2008; 31: 213-217
Year: 2008
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia syndrome
Source: Eur Respir J 2016; 47:1829-1841
Year: 2016
Pulmonary emboli: a rare cause of acute chest syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 47s
Year: 2006
Pulmonary involvement in antisynthetase syndrome: more than myopathy
Source: Virtual Congress 2021 – What's new in respiratory problems in rare and systemic diseases
Year: 2021
A rare cause of hemoptysis: munchausen’s syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 53s
Year: 2004
Broncholithiasis as a cause of pulmonary hemorrhages
Source: Eur Respir J 2007; 30: Suppl. 51, 543s
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept